Related Experiment Video
Updated: Jun 3, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Mild behavioral impairment in idiopathic REM sleep behavior disorder and Lewy body disease continuum
Bora Jin1, Eun Jin Yoon2,3, Kyung Ah Woo4
1Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University of College of Medicine, Seoul, Republic of Korea.
Abstract:
To investigate the clinical impact of mild behavioral impairment (MBI) in a predefined cohort with Lewy body disease (LBD) continuum. Eighty-four patients in the LBD continuum participated in this study, including 35 patients with video-polysomnography-confirmed idiopathic REM sleep behavior disorder (iRBD) and 49 clinically established LBD. Evaluations included the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), neuropsychological tests, and MBI Checklist (MBI-C). We examined the clinical associates of MBI-C and its diagnostic values in predicting disease severity and cognitive impairment across the LBD continuum. Participants were classified into 19 cognitively normal (CN), 45 mild cognitive impairment (MCI), and 20 dementia groups. Median MBI-C total scores were 1.0, 8.0, and 18.5 for CN, MCI, and dementia groups, respectively, with a significant increasing trend (p < 0.001). The MBI-C total score demonstrated significant correlations with the MDS-UPDRS part 1 (r = 0.504, p < 0.001) and total scores (r = 0.508, p < 0.001). Furthermore, significant correlations were observed between MBI-C and cognitive performances in frontal/executive (DSC: r = -0.314, p = 0.006; TMT-B: r = -0.338, p = 0.003) and attentional (TMT-A: r = -0.343, p = 0.002) domains. A cutoff 5.0 effectively differentiated the MCI from CN groups (area under the curve (AUC = 0.74). Furthermore, the MBI-C effectively discriminated the iRBD patients with high phenoconversion risk against those with low-risk (cut-off 4.0, AUC = 0.72). The MBI-C may be a useful screening questionnaire reflecting clinical severity across the LBD continuum. Longitudinal studies are needed to determine its value in monitoring disease progression in prodromal LBD.
Insights
Mild behavioral impairment (MBI) correlates with disease severity in Lewy body disease (LBD) continuum patients. The MBI Checklist (MBI-C) shows diagnostic value in differentiating cognitive stages and predicting phenoconversion risk in idiopathic REM sleep behavior disorder (iRBD).
Area of Science:
- Neurology
- Neuroscience
- Clinical Psychology
Background:
- Lewy body disease (LBD) continuum encompasses idiopathic REM sleep behavior disorder (iRBD) and clinically established LBD.
- Mild behavioral impairment (MBI) is increasingly recognized as a significant clinical feature in neurodegenerative disorders.
- Understanding MBI's impact is crucial for assessing disease severity and progression across the LBD spectrum.
Purpose of the Study:
- To investigate the clinical impact and diagnostic utility of MBI, assessed via the MBI Checklist (MBI-C), in patients with LBD continuum.
- To examine the association between MBI-C scores and clinical/cognitive measures, including disease severity and cognitive impairment.
- To evaluate MBI-C's ability to predict phenoconversion risk in iRBD patients.
Main Methods:
- Eighty-four patients within the LBD continuum (35 iRBD, 49 LBD) were assessed.
- Evaluations included the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), neuropsychological tests, and the MBI Checklist (MBI-C).
- Participants were categorized into cognitively normal (CN), mild cognitive impairment (MCI), and dementia groups.
Main Results:
- MBI-C total scores significantly increased across CN, MCI, and dementia groups (median scores: 1.0, 8.0, 18.5, respectively; p < 0.001).
- MBI-C scores strongly correlated with MDS-UPDRS scores (r=0.504-0.508, p < 0.001) and cognitive deficits in frontal/executive and attentional domains.
- MBI-C demonstrated diagnostic value, differentiating MCI from CN (AUC=0.74) and high-risk from low-risk iRBD patients (AUC=0.72).
Conclusions:
- The MBI Checklist (MBI-C) serves as a valuable screening tool reflecting clinical severity across the Lewy body disease continuum.
- MBI-C effectively distinguishes between cognitive stages and identifies individuals at higher risk of phenoconversion within iRBD.
- Further longitudinal studies are warranted to establish MBI-C's role in monitoring disease progression in prodromal LBD.
More Related Videos
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Parkinson's Disease: Overview
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Narcolepsy